Items where authors include "van Vollenhoven, RF"

Article

Myasoedova, E, Athreya, AP, Crowson, CS et al. (15 more authors) (2022) Towards Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: a Pharmacogenomics-driven Machine Learning Approach. Arthritis Care and Research, 74 (6). pp. 879-888. ISSN 2151-464X

Smolen, JS, Landewé, RB, Bijlsma, JWJ et al. (44 more authors) (2020) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the Rheumatic Diseases. ISSN 0003-4967

Ehlers, L, Askling, J, Bijlsma, HWJ et al. (17 more authors) (2019) 2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis. Annals of the Rheumatic Diseases, 78 (9). pp. 1160-1166. ISSN 0003-4967

Kavanaugh, A, van Vollenhoven, RF, Fleischmann, R et al. (7 more authors) (2018) Testing Treat-to-Target Outcomes With Initial Methotrexate Monotherapy Compared With Initial Tumor Necrosis Factor Inhibitor (Adalimumab) Plus Methotrexate in Early Rheumatoid Arthritis. Annals of the Rheumatic Diseases, 77 (2). pp. 289-292. ISSN 0003-4967

Keystone, EC, Breedveld, FC, Heijde, DVD et al. (8 more authors) (2017) Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone. RMD Open, 3 (2). e000445. ISSN 2056-5933

Weinblatt, ME, Fleischmann, R, van Vollenhoven, RF et al. (8 more authors) (2015) Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population. Arthritis Research and Therapy, 17. 325. ISSN 1478-6354